Leehi Joo1, Ji Eun Park1, Seo Young Park2, Soo Jung Nam3, Young-Hoon Kim4, Jeong Hoon Kim4, Ho Sung Kim1. 1. Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. 2. Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. 3. Deparment of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. 4. Deparment of Neurosurgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Abstract
BACKGROUND: Brain invasion by meningioma is a stand-alone criterion for tumor atypia in the 2016 World Health Organization classification, but no imaging parameter has yet been shown to be sufficient for predicting it. The aim of this study was to develop and validate an MRI-based radiomics model from the brain-to-tumor interface to predict brain invasion by meningioma. METHODS: Preoperative T2-weighted and contrast-enhanced T1-weighted imaging data were obtained from 454 patients (88 patients with brain invasion) between 2012 and 2017. Feature selection was performed from 3222 radiomics features obtained in the 1 cm thickness tumor-to-brain interface region using least absolute shrinkage and selection operator. Peritumoral edema volume, age, sex, and selected radiomics features were used to construct a random forest classifier-based diagnostic model. The performance was evaluated using the areas under the curves (AUCs) of the receiver operating characteristic in an independent cohort of 150 patients (29 patients with brain invasion) between 2018 and 2019. RESULTS: Volume of peritumoral edema was an independent predictor of brain invasion (P < 0.001). The top 6 interface radiomics features plus the volume of peritumoral edema were selected for model construction. The combined model showed the highest performance for prediction of brain invasion in the training (AUC 0.97; 95% CI: 0.95-0.98) and validation sets (AUC 0.91; 95% CI: 0.84-0.98), and improved diagnostic performance over volume of peritumoral edema only (AUC 0.76; 95% CI: 0.66-0.86). CONCLUSION: An imaging-based model combining interface radiomics and peritumoral edema can help to predict brain invasion by meningioma and improve the diagnostic performance of known clinical and imaging parameters.
BACKGROUND: Brain invasion by meningioma is a stand-alone criterion for tumor atypia in the 2016 World Health Organization classification, but no imaging parameter has yet been shown to be sufficient for predicting it. The aim of this study was to develop and validate an MRI-based radiomics model from the brain-to-tumor interface to predict brain invasion by meningioma. METHODS: Preoperative T2-weighted and contrast-enhanced T1-weighted imaging data were obtained from 454 patients (88 patients with brain invasion) between 2012 and 2017. Feature selection was performed from 3222 radiomics features obtained in the 1 cm thickness tumor-to-brain interface region using least absolute shrinkage and selection operator. Peritumoral edema volume, age, sex, and selected radiomics features were used to construct a random forest classifier-based diagnostic model. The performance was evaluated using the areas under the curves (AUCs) of the receiver operating characteristic in an independent cohort of 150 patients (29 patients with brain invasion) between 2018 and 2019. RESULTS: Volume of peritumoral edema was an independent predictor of brain invasion (P < 0.001). The top 6 interface radiomics features plus the volume of peritumoral edema were selected for model construction. The combined model showed the highest performance for prediction of brain invasion in the training (AUC 0.97; 95% CI: 0.95-0.98) and validation sets (AUC 0.91; 95% CI: 0.84-0.98), and improved diagnostic performance over volume of peritumoral edema only (AUC 0.76; 95% CI: 0.66-0.86). CONCLUSION: An imaging-based model combining interface radiomics and peritumoral edema can help to predict brain invasion by meningioma and improve the diagnostic performance of known clinical and imaging parameters.
Authors: Lara Brunasso; Gianluca Ferini; Lapo Bonosi; Roberta Costanzo; Sofia Musso; Umberto E Benigno; Rosa M Gerardi; Giuseppe R Giammalva; Federica Paolini; Giuseppe E Umana; Francesca Graziano; Gianluca Scalia; Carmelo L Sturiale; Rina Di Bonaventura; Domenico G Iacopino; Rosario Maugeri Journal: Life (Basel) Date: 2022-04-14
Authors: Norbert Galldiks; Frank Angenstein; Jan-Michael Werner; Elena K Bauer; Robin Gutsche; Gereon R Fink; Karl-Josef Langen; Philipp Lohmann Journal: Brain Pathol Date: 2022-03 Impact factor: 6.508
Authors: Darius Kalasauskas; Michael Kosterhon; Naureen Keric; Oliver Korczynski; Andrea Kronfeld; Florian Ringel; Ahmed Othman; Marc A Brockmann Journal: Cancers (Basel) Date: 2022-02-07 Impact factor: 6.639